Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6431) 6431
Book Review (890) 890
Newsletter (313) 313
Publication (208) 208
Conference Proceeding (25) 25
Book Chapter (21) 21
Magazine Article (17) 17
Dissertation (8) 8
Newspaper Article (5) 5
Web Resource (3) 3
Book / eBook (1) 1
Government Document (1) 1
Reference (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (4714) 4714
humans (4493) 4493
sulfasalazine (3355) 3355
male (2457) 2457
sulfasalazine - therapeutic use (2369) 2369
female (2337) 2337
adult (1850) 1850
middle aged (1521) 1521
rheumatology (1106) 1106
sulfasalazine - adverse effects (1075) 1075
arthritis, rheumatoid - drug therapy (1038) 1038
colitis, ulcerative - drug therapy (973) 973
aged (895) 895
abridged index medicus (890) 890
rheumatoid arthritis (823) 823
methotrexate (798) 798
antirheumatic agents - therapeutic use (719) 719
animals (703) 703
treatment outcome (694) 694
drug therapy, combination (639) 639
gastroenterology & hepatology (621) 621
sulfasalazine - pharmacology (593) 593
anti-inflammatory agents, non-steroidal - therapeutic use (585) 585
adolescent (577) 577
sulfasalazine - administration & dosage (548) 548
double-blind (531) 531
mesalamine (528) 528
pharmacology & pharmacy (526) 526
crohn disease - drug therapy (517) 517
methotrexate - therapeutic use (500) 500
ulcerative colitis (491) 491
therapy (447) 447
drug therapy (394) 394
ulcerative-colitis (384) 384
research (369) 369
sulphasalazine (365) 365
medicine, general & internal (357) 357
time factors (356) 356
arthritis (345) 345
5-aminosalicylic acid (344) 344
rats (329) 329
rheumatoid-arthritis (323) 323
care and treatment (320) 320
child (314) 314
inflammatory bowel disease (312) 312
disease (295) 295
severity of illness index (289) 289
antirheumatic agents - adverse effects (283) 283
aminosalicylic acids - therapeutic use (267) 267
double-blind method (265) 265
adrenal cortex hormones - therapeutic use (263) 263
inflammatory-bowel-disease (263) 263
crohns-disease (262) 262
follow-up studies (257) 257
dose-response relationship, drug (255) 255
anti-inflammatory agents, non-steroidal - adverse effects (252) 252
immunosuppressive agents - therapeutic use (248) 248
infliximab (247) 247
anti-inflammatory agents - therapeutic use (241) 241
drugs (238) 238
analysis (237) 237
mice (234) 234
clinical trials as topic (232) 232
etanercept (232) 232
medicine & public health (230) 230
placebo (229) 229
administration, oral (228) 228
efficacy (224) 224
inflammatory bowel diseases - drug therapy (220) 220
crohn's disease (219) 219
mesalamine - therapeutic use (216) 216
inflammation (215) 215
hydroxychloroquine (211) 211
azathioprine - therapeutic use (210) 210
prednisolone - therapeutic use (209) 209
recurrence (209) 209
inflammatory bowel-disease (207) 207
pregnancy (207) 207
mesalazine (199) 199
leflunomide (198) 198
prednisone - therapeutic use (198) 198
antirheumatic agents - administration & dosage (197) 197
spondylitis, ankylosing - drug therapy (195) 195
ankylosing spondylitis (194) 194
risk factors (194) 194
prospective studies (191) 191
anti-inflammatory agents, non-steroidal - administration & dosage (190) 190
patients (190) 190
retrospective studies (186) 186
sulfasalazine - metabolism (184) 184
colitis (183) 183
colitis, ulcerative - complications (177) 177
prognosis (177) 177
remission induction (176) 176
rheumatoid factor (176) 176
combination therapy (175) 175
radiography (174) 174
trial (171) 171
cancer (168) 168
hydroxychloroquine - therapeutic use (160) 160
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5832) 5832
German (294) 294
French (188) 188
Japanese (107) 107
Russian (58) 58
Spanish (53) 53
Italian (43) 43
Chinese (31) 31
Dutch (30) 30
Danish (27) 27
Polish (20) 20
Hungarian (19) 19
Korean (19) 19
Portuguese (16) 16
Czech (12) 12
Finnish (10) 10
Norwegian (9) 9
Swedish (9) 9
Hebrew (8) 8
Turkish (8) 8
Romanian (6) 6
Bulgarian (3) 3
Croatian (3) 3
Lithuanian (1) 1
Persian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text L'oeil : miroir de la spondylarthrite systemique ?
by Rahmouni, S and Dhahri, R and Metoui, L and Slouma, M and Boussetta, N and Laajili, F and Louzir, B and Gharsallah, I and Othmani, S
La Revue de medecine interne, ISSN 0248-8663, 12/2017, Volume 38, p. A204
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/j.revmed.2017.10.198 Les... 
Sulfasalazine
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text A rare reaction to sulfasalazine
by Pinnell, Jonathan and Potter, Tanya
BMJ, ISSN 0959-8138, 11/2017, p. j5189
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text A solid-phase luminescence sensor based on molecularly imprinted polymer-CdSeS/ZnS quantum dots for selective extraction and detection of sulfasalazine in biological samples
by Ahmadpour, Hamidreza and Hosseini, Seyed Mohamadreza Milani
Talanta, ISSN 0039-9140, 03/2019, Volume 194, pp. 534 - 541
A new solid phase luminescence sensor (SPLS) based on molecularly imprinted polymer (MIP) as recognition element and semi-conductor CdSeS/ZnS alloyed quantum... 
Solid phase extraction | Sulfasalazine | Quantum dot | Molecularly imprinted polymer | Fluorescence detection | CHEMISTRY, ANALYTICAL | METABOLITES | RAPID-DETERMINATION | SERUM | CARBON-DOTS | HIGH-SENSITIVITY | FLUORESCENCE | WATER | Limit of Detection | Sulfasalazine - analysis | Cadmium Compounds - chemistry | Polymers - chemical synthesis | Humans | Sulfides - chemistry | Glass - chemistry | Molecular Imprinting | Sulfasalazine - urine | Zinc Compounds - chemistry | Sulfasalazine - isolation & purification | Quantum Dots - chemistry | Time Factors | Sulfasalazine - blood | Polymers - chemistry | Selenium Compounds - chemistry | Luminescent Measurements - instrumentation | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. An Uncontrolled, Open label Study of Sulfasalazine in Severe Alopecia Areata
by Aghaei, Shahin
10/2009
Background: Alopecia areata (AA) is an autoimmune disease mediated by T lymphocytes. Many treatments have been used but their results remain disappointing.... 
Treatment | Sulfasalazine | Alopecia areata
Web Resource
Details down arrow
5. Full Text Mucoadhesive chitosan hydrogels as rectal drug delivery vessels to treat ulcerative colitis
by Xu, Jinke and Tam, Mifong and Samaei, Sepideh and Lerouge, Sophie and Barralet, Jake and Stevenson, Mary M and Cerruti, Marta
Acta Biomaterialia, ISSN 1742-7061, 01/2017, Volume 48, pp. 247 - 257
Mucoadhesive drug delivery systems stick to mucosal tissues and prolong the local retention time of drugs. Since the colon is covered by a mucosal layer,... 
Catechols | Rectal drug delivery | Chitosan | Mucoadhesion | Ulcerative colitis | ACID DERMAL FILLERS | MATERIALS SCIENCE, BIOMATERIALS | RHEOLOGICAL PROPERTIES | ENGINEERING, BIOMEDICAL | RANDOMIZED-TRIAL | EPITHELIAL ION-TRANSPORT | 5-AMINOSALICYLIC ACID | MOUSE MODELS | INFLAMMATORY-BOWEL-DISEASE | ACETAMINOPHEN LIQUID SUPPOSITORY | DOUBLE-BLIND | BIOMEDICAL APPLICATIONS | Sulfasalazine - therapeutic use | Tumor Necrosis Factor-alpha - metabolism | Colon - pathology | Colon - drug effects | Body Weight - drug effects | Catechols - chemistry | Sulfasalazine - pharmacology | Colitis, Ulcerative - pathology | Mucins - chemistry | Sulfasalazine - metabolism | Colitis, Ulcerative - blood | Adhesives - chemistry | Drug Delivery Systems | Dose-Response Relationship, Drug | Animals | Chitosan - chemistry | Rectum - drug effects | Sulfasalazine - blood | Mice | Occult Blood | Colitis, Ulcerative - drug therapy | Hydrogels - chemistry | Drugs | Drug delivery systems | Drug therapy | Vehicles | Hypertension | Evaluation | Colon cancer | Aminosalicylic acids | Microbiota (Symbiotic organisms) | Analysis | Gastrointestinal system | Inflammatory bowel diseases | Hydrogels | Mucosa | Medical services | Drug delivery | Sulfapyridine | Retention time | Tissues | Retention | Small intestine | Genipin | Degradation | Absorption | Rodents | Sulfasalazine | Colon | Intestinal microflora | Formulations | Effectiveness | Degradation products | Vessels | Oral administration | Byproducts | Crosslinking | Gastrointestinal tract | Catechol | Inflammatory bowel disease | Side effects | Flora | Rectum | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Enzyme-responsive controlled release of covalently bound prodrug from functional mesoporous silica nanospheres
by Popat, Amirali and Ross, Benjamin P and Liu, Jian and Jambhrunkar, Siddharth and Kleitz, Freddy and Qiao, Shi Zhang
Angewandte Chemie - International Edition, ISSN 1433-7851, 12/2012, Volume 51, Issue 50, pp. 12486 - 12489
I want to break free: Mesoporous silica nanoparticles are functionalized with sulfasalazine (SZ; see scheme), a prodrug of 5-aminosalicylic acid (5-ASA) and... 
colon targeting | sulfasalazine | nanoparticles | drug delivery | azo-reductase | BIOCOMPATIBILITY | DRUG-DELIVERY | GUEST MOLECULES | OPERATED MECHANIZED NANOPARTICLES | BIODISTRIBUTION | CARRIERS | CHEMISTRY, MULTIDISCIPLINARY | IMMOBILIZATION | GENE | BIOADSORPTION | Sulfapyridine - metabolism | Oxidoreductases - metabolism | Nanospheres - chemistry | Silicon Dioxide - chemistry | Sulfapyridine - chemistry | Prodrugs - chemistry | Sulfasalazine - metabolism | Drug Carriers - chemistry | Prodrugs - metabolism | Mesalamine - chemistry | Sulfasalazine - chemistry | Porosity | Mesalamine - metabolism | Hydrogen-Ion Concentration | Drugs | Sulfasalazine | Drug delivery systems | Silica | Vehicles | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Diclofenac-β-cyclodextrin for colonic drug targeting: In vivo performance in rats
by Vieira, Amélia C.F and Serra, Arménio C and Veiga, Francisco J and Gonsalves, António M.d’A Rocha and Basit, Abdul W and Murdan, Sudaxshina
International Journal of Pharmaceutics, ISSN 0378-5173, 03/2016, Volume 500, Issue 1-2, pp. 366 - 370
The aim of this study was to assess the ability of the prodrug conjugate diclofenac-β-cyclodextrin to release diclofenac in the colon following oral... 
Colonic targeting | Microbiota | Cyclodextrin | Conjugate | Large intestine | Gut | ACID | BACTERIAL METABOLISM | GASTROINTESTINAL PHYSIOLOGY | DELIVERY | PRODRUG | PHARMACOKINETICS | SULFASALAZINE | SYSTEMS | PHARMACOLOGY & PHARMACY | Prodrugs - administration & dosage | Prodrugs - analysis | Rats, Wistar | Anti-Inflammatory Agents, Non-Steroidal - chemistry | Male | Prodrugs - chemistry | beta-Cyclodextrins - pharmacokinetics | Anti-Inflammatory Agents, Non-Steroidal - blood | Diclofenac - chemistry | Intestinal Absorption | Drug Delivery Systems | Sulfasalazine - chemistry | Sulfasalazine - pharmacokinetics | Sulfasalazine - blood | Administration, Oral | Diclofenac - blood | Colon - metabolism | Diclofenac - pharmacokinetics | Sulfasalazine - administration & dosage | Animals | beta-Cyclodextrins - administration & dosage | beta-Cyclodextrins - chemistry | Prodrugs - pharmacokinetics | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics | Drug Liberation | Diclofenac - administration & dosage | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Therapies for Active Rheumatoid Arthritis after Methotrexate Failure
by O'Dell, James R and Mikuls, Ted R and Taylor, Thomas H and Ahluwalia, Vandana and Brophy, Mary and Warren, Stuart R and Lew, Robert A and Cannella, Amy C and Kunkel, Gary and Phibbs, Ciaran S and Anis, Aslam H and Leatherman, Sarah and Keystone, Edward and CSP 551 RACAT Investigators
The New England Journal of Medicine, ISSN 0028-4793, 07/2013, Volume 369, Issue 4, pp. 307 - 318
In a 48-week trial in patients with active rheumatoid arthritis despite treatment with methotrexate, adding sulfasalazine and hydroxychloroquine to... 
MEDICINE, GENERAL & INTERNAL | MODIFYING ANTIRHEUMATIC DRUGS | NECROSIS-FACTOR | PLACEBO | COMBINATION THERAPY | INADEQUATE RESPONSE | PHASE-III | DOUBLE-BLIND | PLUS METHOTREXATE | COLLEGE-OF-RHEUMATOLOGY | DISEASE-ACTIVITY | Hydroxychloroquine - therapeutic use | Severity of Illness Index | Sulfasalazine - therapeutic use | Double-Blind Method | Humans | Middle Aged | Immunoglobulin G - therapeutic use | Male | Hydroxychloroquine - adverse effects | Methotrexate - therapeutic use | Immunoglobulin G - adverse effects | Receptors, Tumor Necrosis Factor - therapeutic use | Methotrexate - adverse effects | Etanercept | Arthritis, Rheumatoid - drug therapy | Treatment Failure | Antirheumatic Agents - adverse effects | Female | Aged | Drug Therapy, Combination | Sulfasalazine - adverse effects | Antirheumatic Agents - therapeutic use | Care and treatment | Antirheumatic agents | Research | Comparative analysis | Rheumatoid arthritis | Hydroxychloroquine | Pain | Clinical trials | TNF inhibitors | Sulfasalazine | Methotrexate | Drug therapy | Patients | Quality of life | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Glutamate release by primary brain tumors induces epileptic activity
by Buckingham, Susan C and Campbell, Susan L and Haas, Brian R and Montana, Vedrana and Robel, Stefanie and Ogunrinu, Toyin and Sontheimer, Harald
Nature Medicine, ISSN 1078-8956, 10/2011, Volume 17, Issue 10, pp. 1269 - 1274
Epileptic seizures are a common and poorly understood comorbidity for individuals with primary brain tumors. To investigate peritumoral seizure etiology, we... 
MEDICINE, RESEARCH & EXPERIMENTAL | CELLS | TRANSPORTER | BIOCHEMISTRY & MOLECULAR BIOLOGY | EPILEPTOGENESIS | CELL BIOLOGY | INVASION | MICRODIALYSIS | EXTRACELLULAR MAGNESIUM | SEIZURE | GROWTH | SULFASALAZINE | MALIGNANT GLIOMAS | Sulfasalazine - therapeutic use | Humans | Electrophysiology | Cell Transplantation | Sulfasalazine - pharmacology | Electroencephalography | Brain Neoplasms - complications | Brain Neoplasms - drug therapy | Mice, SCID | Epilepsy - etiology | Brain Neoplasms - metabolism | Glioma - metabolism | Amino Acid Transport System y+ - metabolism | Animals | Analysis of Variance | Amino Acid Transport System y+ - antagonists & inhibitors | Glutamic Acid - metabolism | Mice | Epilepsy - pathology | Glioma - drug therapy | Complications and side effects | Prognosis | Epilepsy | Brain tumors | Physiological aspects | Development and progression | Genetic aspects | Research | Glutamate | Risk factors | Brain | Convulsions & seizures | Biomedical research | Tumors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Multi-laminated metal hydroxide nanocontainers for oral-specific delivery for bioavailability improvement and treatment of inflammatory paw edema in mice
by Kankala, Shravankumar and Kankala, Ranjith Kumar and Kuthati, Yaswanth and Sie, Huei-Wun and Shih, Hung-Yuan and Lue, Sheng-I and Jeng, Chien-Chung and Deng, Jin-Pei and Weng, Ching-Feng and Liu, Chen-Lun and Lee, Chia-Hung
Journal of Colloid And Interface Science, ISSN 0021-9797, 11/2015, Volume 458, pp. 217 - 228
Multiple layers of pH-sensitive enteric copolymers were coated over layered double hydroxide (LDH) nanoparticles for controllable drug release and improved... 
Nanoparticles | Eudragit copolymer | Inflammatory | Sulfasalazine | Oral drug delivery | Layered double hydroxides | ACID | DRUG-DELIVERY | INORGANIC-POLYMER NANOHYBRID | ANTICANCER AGENT | CONTROLLED-RELEASE | CHEMISTRY, PHYSICAL | IN-VITRO | MESOPOROUS SILICA SHELL | LAYERED DOUBLE HYDROXIDE | SUSTAINED-RELEASE | Sulfasalazine - therapeutic use | Hydroxides - chemistry | Nanoparticles - chemistry | Humans | Biological Availability | Sulfasalazine - pharmacology | Edema - drug therapy | Polymethacrylic Acids - chemistry | Spectroscopy, Fourier Transform Infrared | Drug Carriers - chemistry | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | HT29 Cells | Animals | Sulfasalazine - pharmacokinetics | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Inflammation - drug therapy | Cell Line, Tumor | Mice | Laminated metals | Hydroxides | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Sulfasalazine augments a pro-inflammatory response in interleukin-1[beta]-stimulated amniocytes and myocytes
by Sykes, Lynne and Thomson, Kacie R and Boyce, Emily J and Lee, Yun S and Rasheed, Zahirrah B. M and MacIntyre, David A and Teoh, Tiong Ghee and Bennett, Phillip R
Immunology, ISSN 0019-2805, 12/2015, Volume 146, Issue 4, p. 630
Preterm birth occurs in 10% of pregnancies and is a major cause of neonatal morbidity and mortality. The majority of cases of early preterm labour are... 
Brain | Sulfasalazine | Interleukins | Injuries
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text SAPHO syndrome/SAPHO-Syndrom
by Heldmann, F and Kiltz, U and Baraliakos, X and Braun, J
Zeitschrift fur Rheumatologie, ISSN 0340-1855, 10/2014, Volume 73, Issue 8, p. 729
Das Synovitis, Akne, Hyperostose, Pustulose und Osteitis (SAPHO)-Syndrom ist eine seltene Erkrankung, die sich an Knochen, Gelenken und der Haut manifestiert.... 
Sulfasalazine | Methotrexate
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Association polychondrite atrophiante, maladie de Crohn, spondylarthropathie B27, syndrome de Sweet et vascularite a ANCA
by Witkowski, P and Guilpain, P and Maria, A and Goulabchand, R and Mura, F and Riviere, S and Rullier, P and Le Quellec, A and Konate, A
La Revue de medecine interne, ISSN 0248-8663, 06/2018, Volume 39, p. A168
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/j.revmed.2018.03.117 La... 
Corticosteroids | Sulfasalazine | Immunosuppressive agents
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Uveites de l'adulte : que doit savoir le rhumatologue ?
by Seve, Pascal and Kodjikian, Laurent and Adelaide, LeOpold and Jamilloux, Yvan
Revue du rhumatisme, ISSN 1169-8330, 10/2015, Volume 82, Issue 5, p. 298
Le rhumatologue peut etre sollicite tant pour le diagnostic etiologique que pour la prise en charge therapeutique d'une uveite. A ce jour, aucune etude... 
Phosphonates | Sulfasalazine
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: A randomized trial
by Goldbach-Mansky, Raphaela and Wilson, Mildred and Fleischmann, Roy and Olsen, Nancy and Silverfield, Joel and Kempf, Phillip and Kivitz, Alan and Sherrer, Yvonne and Pucino, Frank and Csako, Gyorgy and Costello, Rene and Pham, Tuyet Hang and Snyder, Christopher and Van Der Heijde, Désirée and Tao, Xuelian and Wesley, Robert and Lipsky, Peter E
Annals of Internal Medicine, ISSN 0003-4819, 2009, Volume 151, Issue 4, pp. 229 - 240
Background: Extracts of the medicinal plant Tripterygium wilfordii Hook F (TwHF) have been used in China for centuries to treat a spectrum of inflammatory... 
MEDICINE, GENERAL & INTERNAL | MODIFYING ANTIRHEUMATIC DRUGS | EFFICACY | DISEASE | DOUBLE-BLIND | METHOTREXATE | INHIBITOR | NF-KAPPA-B | LEFLUNOMIDE | TRIPTOLIDE | EXTRACT | Sulfasalazine - therapeutic use | Humans | Middle Aged | Tripterygium | Male | Phytotherapy - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Arthritis, Rheumatoid - drug therapy | Antirheumatic Agents - adverse effects | Adult | Female | Aged | Patient Compliance | Drug Therapy, Combination | Sulfasalazine - adverse effects | Plant Extracts - therapeutic use | Gastrointestinal Diseases - chemically induced | Prednisone - therapeutic use | Antirheumatic Agents - therapeutic use | Plant Extracts - adverse effects | Usage | Care and treatment | Rheumatoid arthritis | Patient outcomes | Sulfasalazine | Dosage and administration | Research | Comparative analysis | Thunder god vine | Health aspects | Materia medica, Vegetable | Plant extracts | Clinical trials | Medical treatment | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Curcumin Maintenance Therapy for Ulcerative Colitis: Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial
by Hanai, Hiroyuki and Iida, Takayuki and Takeuchi, Ken and Watanabe, Fumitoshi and Maruyama, Yasuhiko and Andoh, Akira and Tsujikawa, Tomoyuki and Fujiyama, Yosihihide and Mitsuyama, Keiichi and Sata, Michio and Yamada, Masami and Iwaoka, Yasushi and Kanke, Kazunari and Hiraishi, Hideyuki and Hirayama, Kazuhisa and Arai, Hajime and Yoshii, Shigehito and Uchijima, Masato and Nagata, Toshi and Koide, Yukio
Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 2006, Volume 4, Issue 12, pp. 1502 - 1506
Curcumin is a biologically active phytochemical substance present in turmeric and has pharmacologic actions that might benefit patients with ulcerative colitis... 
CELLS | ACTIVATION | INFLAMMATORY-BOWEL-DISEASE | INHIBITION | SULPHASALAZINE | MEDICAL THERAPY | GENE-EXPRESSION | SULFASALAZINE | FACTOR-KAPPA-B | SUPPRESSION | GASTROENTEROLOGY & HEPATOLOGY | Sulfasalazine - therapeutic use | Curcumin - therapeutic use | Double-Blind Method | Follow-Up Studies | Administration, Oral | Humans | Middle Aged | Male | Treatment Outcome | Colitis, Ulcerative - pathology | Curcumin - administration & dosage | Sulfasalazine - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Colonoscopy | Adolescent | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Mesalamine - therapeutic use | Adult | Female | Aged | Retrospective Studies | Colitis, Ulcerative - drug therapy | Drug Therapy, Combination | Mesalamine - administration & dosage | Clinical trials | Care and treatment | Ulcerative colitis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights